ScholarIQanswers from OpenAlex

Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile

PaperCitations, authors & open-access status

Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile have?

ScholarIQcitation count

Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile has 187 citations in the OpenAlex counts ScholarIQ stores.

When was Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile published?

ScholarIQyear

Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile has 1993 year in the ScholarIQ index.

What is the open-access status of Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile?

ScholarIQoa status

Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile has closed oa status in the ScholarIQ index.

What is the DOI of Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile?

ScholarIQdoi

The DOI for Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile is on the source record.

What is the PMID of Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile?

ScholarIQpmid

The PMID for Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile is on the source record.

What is the OpenAlex record for Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile?

ScholarIQopenalex

The OpenAlex for Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial